D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Axsome Therapeutics
AXSM
$6.14B
| $895K | ﹤0.01% |
+34,756
| New | +$895K |
|
1877
Natera
NTRA
$23.9B
| $891K | ﹤0.01% |
32,309
-137,729
| -81% | -$3.8M |
|
1878
Cytokinetics
CYTK
$6.38B
| $889K | ﹤0.01% |
78,994
-128,245
| -62% | -$1.44M |
|
|
DNR
1879
DELISTED
Denbury Resources, Inc.
DNR
| $889K | ﹤0.01% |
717,438
-1,559,467
| -68% | -$1.93M |
|
|
UFS
1880
DELISTED
DOMTAR CORPORATION (New)
UFS
| $888K | ﹤0.01% |
19,950
-12,966
| -39% | -$577K |
|
1881
CryoPort
CYRX
$474M
| $887K | ﹤0.01% |
48,429
+783
| +2% | +$14.3K |
|
|
JBTM
1882
JBT Marel Corporation
JBTM
$7.28B
| $887K | ﹤0.01% |
7,322
-43,354
| -86% | -$5.25M |
|
|
ISEE
1883
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $886K | ﹤0.01% |
681,661
-900
| -0.1% | -$1.17K |
|
|
INVX
1884
Innovex International, Inc.
INVX
$1.16B
| $883K | ﹤0.01% |
18,393
-10,564
| -36% | -$507K |
|
1885
The GEO Group
GEO
$3.26B
| $878K | ﹤0.01% |
41,787
-24,113
| -37% | -$507K |
|
|
CYOU
1886
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $876K | ﹤0.01% |
91,133
-90,490
| -50% | -$870K |
|
1887
Motorcar Parts of America
MPAA
$310M
| $874K | ﹤0.01% |
+40,821
| New | +$874K |
|
|
SYRS
1888
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $873K | ﹤0.01% |
9,433
-1,836
| -16% | -$170K |
|
1889
Olympic Steel
ZEUS
$378M
| $870K | ﹤0.01% |
63,708
+14,394
| +29% | +$197K |
|
|
ENZ
1890
DELISTED
Enzo Biochem, Inc.
ENZ
| $869K | ﹤0.01% |
257,796
-36,157
| -12% | -$122K |
|
|
CCXI
1891
DELISTED
ChemoCentryx, Inc.
CCXI
| $867K | ﹤0.01% |
93,210
-33,149
| -26% | -$308K |
|
|
ONIT
1892
Onity Group Inc.
ONIT
$366M
| $866K | ﹤0.01% |
27,895
+422
| +2% | +$13.1K |
|
1893
Methode Electronics
MEI
$289M
| $865K | ﹤0.01% |
+30,273
| New | +$865K |
|
1894
Reinsurance Group of America
RGA
$12.9B
| $865K | ﹤0.01% |
5,547
-2,285
| -29% | -$356K |
|
1895
J&J Snack Foods
JJSF
$2.09B
| $863K | ﹤0.01% |
5,359
+1,607
| +43% | +$259K |
|
|
HTB
1896
HomeTrust Bancshares, Inc.
HTB
$725M
| $860K | ﹤0.01% |
34,198
-2,856
| -8% | -$71.8K |
|
1897
Tyler Technologies
TYL
$24B
| $858K | ﹤0.01% |
3,970
-15,830
| -80% | -$3.42M |
|
|
SMTA
1898
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $857K | ﹤0.01% |
102,704
-57,954
| -36% | -$484K |
|
1899
BP
BP
$88.8B
| $855K | ﹤0.01% |
+20,859
| New | +$855K |
|
1900
Barings BDC
BBDC
$995M
| $850K | ﹤0.01% |
86,385
+2,175
| +3% | +$21.4K |
|